Convergent R.N.R.

X-ray Focusing for Cancer Treatment

Health Tech & Life Sciences
Active
Mature Haifa, Israel Founded 2010
Last updated 2026-06-18
Total raised
$3.7M
Last: 2017-12
Stage
Mature
Founded
2010
Headcount
17
HQ
Haifa, Israel
Sector
Health Tech & Life Sciences

About

Convergent Radiotherapy and Radiosurgery is a medical start-up developing a new X-ray-focusing technology called MercyBeam. The companys patented technology uses a standard imaging X-ray source to form a converging beam into a volume of treatment, rather than the standard diverging one. This development is designed to render radiotherapy treatment more accurate and safe and to spare healthy organs and cells. MercyBeam introduces a lens that collects most of the X-rays emanating divergently out of any standard X-ray tube and converges themtoward the tumors location. The lens simultaneously removes low-energy photons that would be absorbed by the patients skin. The convergence increases the therapeutic dose delivered at the tumor location, while the organs in the vicinity of the tumor receive a very low dose or none at all. The converging technology enables the use of photon-energy X-rays 100 times lower than those used by current systems based on linear accelerators.

Funding history · 2 rounds · $3.7M total

2017-12
$3.0M
Date unknown

Q&A

What is Convergent R.N.R.'s primary focus?
Convergent R.N.R. is a medical startup developing MercyBeam, a new X-ray focusing technology for cancer treatment.
What is the core technology behind MercyBeam?
MercyBeam uses a patented lens technology to collect X-rays from a standard source and converge them towards a tumor, rather than using a diverging beam. It also removes low-energy photons that would be absorbed by the patient's skin.
What are the benefits of Convergent R.N.R.'s MercyBeam technology?
The MercyBeam technology is designed to make radiotherapy treatment more accurate and safe, sparing healthy organs and cells. It increases the therapeutic dose at the tumor while reducing exposure to surrounding organs, and allows for the use of photon-energy X-rays 100 times lower than current systems.
When was Convergent R.N.R. founded?
Convergent R.N.R. was founded in September 2010.
What is Convergent R.N.R.'s employee count?
Convergent R.N.R. has 11-50 employees.
What is the total amount of funding raised by Convergent R.N.R.?
Convergent R.N.R. has raised a total of $3,700,000.
When was Convergent R.N.R.'s last funding round and how much was raised?
Convergent R.N.R.'s last funding round was in December 2017, raising $3,000,000.
Which investor participated in an earlier funding round for Convergent R.N.R.?
The Office of the Chief Scientist participated in an earlier funding round for Convergent R.N.R.
What is the current product stage of Convergent R.N.R.'s technology?
Convergent R.N.R.'s product is currently released.

Team · 4

Founder · Co-founder & CEO
LinkedIn ↗
Founder · Co-Founder & Chief physicist
LinkedIn ↗
Founder · Co-founder
LinkedIn ↗
Founder · Co-founder
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Simulation & Imaging
Target customers
Healthcare & Life SciencesHealthcarePatientsProviders
Business model
B2B

Highlights

1 PatentsVerified

Tags

medical-technologiescanceroncologyx-raylensesradiologybabiesmedical-deviceshealthcare-providersnon-invasivehospitalschildrenpatientsimagingoptronicstreatmentsbioconvergence
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)